Robert T. Striker, MD, PhD

Associate Professor of Medicine

Dr. Striker studies how kinase inhibitors can be used as anti-infective strategies for viral and bacterial pathogens. Recently he has published 4 papers that collectively show that not only can the human kinome be selectively inhibited, but that one bacterial kinase can be selectively inhibited from another to resensitize antibiotic resistant bacteria to beta lactam antibiotics. He is also working on the relationship between immune recovery in treated HIV patients and HIV reservoir reduction. This involves both novel technology to monitor the reservoir as well as clinical cohorts in which immune homeostasis is perturbed, such as clearance of Hepatitis C virus in HIV/HCV co-infected patients. He continues to work on access to Hepatitis C treatment for those incarcerated or recently released. Dr. Striker has been collaborating with Drs. Bernard, Gumperz, Sherer, Friedrich, and Westergaard. Dr. Striker’s lab is supported by a VA MERIT award.